Skip to main content

Table 2 Comparison of stool microscopic outcomes between Intervention and Placebo groups of patients with shigellosis a

From: Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial

 

No. of patient improved n (%) compared to day 1

Odds ratiob(95%CI)

p valueb

Microscopic features in stool

Intervention group n = 39

Placebo group n = 37

  

RBC at day-2

29 (74.4)

22 (59.5)

1.85 (0.7-4.9)

0.22

RBC at day-3

32 (82))

31 (83.8)

0.88 (0.3-2.9)

1.0

Pus cell at day-2

30 (76.9)

17 (45.9)

3.72 (1.4-10)

0.009

Pus cell at day-3

32 (82)

30 (81.1)

1.1 (0.3-3.4)

1.0

Macrophage at day-2

32 (82)

22 (59.5)

3.12 (1.1-8.9)

0.043

Macrophage at day-3

38 (97.4)

34 (91.9)

3.3 (0.3-33.8)

0.35

  1. Abbreviations: RBC Red blood cell, CI Confidence interval.
  2. aData are given as number of patients (% of total patients in each group).
  3. bChi-square test was used to compare between the groups. Significance: p≤ 0.05.